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Selection on running capacity has created rat phenotypes of high-capacity runners (HCRs)
that have enhanced cardiac function and low-capacity runners (LCRs) that exhibit risk factors
of metabolic syndrome. We analysed hearts of HCRs and LCRs from generation 22 of
selection using DIGE and identified proteins from MS database searches. The running
capacity of HCRs was six-fold greater than LCRs. DIGE resolved 957 spots and proteins were
unambiguously identified in 369 spots. Protein expression profiling detected 67 statistically
significant (po0.05; false discovery rate o10%, calculated using q-values) differences
between HCRs and LCRs. Hearts of HCR rats exhibited robust increases in the abundance of
each enzyme of the b-oxidation pathway. In contrast, LCR hearts were characterised by the
modulation of enzymes associated with ketone body or amino acid metabolism. LCRs also
exhibited enhanced expression of antioxidant enzymes such as catalase and greater phos-
phorylation of a B-crystallin at serine 59, which is a common point of convergence in cardiac
stress signalling. Thus, proteomic analysis revealed selection on low running capacity is
associated with perturbations in cardiac energy metabolism and provided the first evidence
that the LCR cardiac proteome is exposed to greater oxidative stress.
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1 Introduction
Divergent selection on running capacity has produced two
populations of rats, high-capacity runners (HCRs) and low-
capacity runners (LCRs), which have the potential to illu-
minate mechanisms underlying diseases associated with
low cardiorespiratory fitness. Genetic heterogeneity of HCR-
LCR lines is maintained by a rotational mating paradigm
that minimises inbreeding [1], and concurrent breeding of
LCRs and HCRs enables the lines to serve as reciprocal
controls for unknown environmental changes. Compared
with inbred strains, in which essentially all loci are fixed,
these outbred selected lines maintain genetic complexity,
allowing allelic variants to be enriched by selection pressure
[2]. As a result, the HCR-LCR model is ideally suited to
discovering the resultant effects of epistatic interactions,
modifier genes or synergistic actions associated with
different levels of aerobic capacity.
Sedentary HCRs and LCRs exhibit substantial differences
in aerobic capacity, disease susceptibility and mortality rate.
LCRs are relatively hypertensive, have poorer vascular
function and higher fasting blood levels of glucose, insulin,
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triacylglycerides and free fatty acids [3]. LCRs are also more
susceptible to environmental challenges such as ischaemia/
reperfusion [4], high-fat diet [5] or hypoxia [6]. Exposure to
hypoxia (7% oxygen) induces cardiac pump failure more
rapidly in LCRs than HCRs [6]. That is, LCRs experience fatal
irregular ventricular contractions within 8 min of hypoxia; in
contrast, pump failure in HCRs occurs after 20 min of
hypoxia and is characterised by a gradual diminution of
cardiac systolic performance. At the cellular level, cardio-
myocytes from LCRs are significantly shorter, contract less
quickly and relax more slowly than those isolated from HCRs
[6]. These differences are accompanied by greater expression
of b-myosin heavy chain and differences in Ca11 transients,
but the expression of proteins associated with Ca11 hand-
ling; sarco-endoplasmic reticulum ATPase, phospholamban,
Na1–Ca11 exchanger or calsequestrin is similar in LCR and
HCR hearts [6]. Therefore, the mechanisms responsible for
contractile dysfunction associated with selection on low
running capacity are not yet fully understood.
Molecular differences that regress with low running
capacity may provide further mechanistic insight to the
elevated disease risk and cardiac dysfunction observed in
LCR rats and individuals with low aerobic capacity. Micro-
array analysis [7] of HCR-LCR hearts detected 1540 differ-
ences in gene expression and highlighted enrichment of
genes involved in lipid metabolism in HCRs, whereas
glucose metabolism and microtubule-based processes were
enriched in LCRs. However, alterations in gene expression
do not necessarily result in concomitant changes in protein
abundance and post-translational processes can give rise to
protein species that are undetectable in microarray analyses.
The protein complement of a cell (i.e. its proteome) defines
that cell and dictates its functional characteristics. There-
fore, it is of mechanistic value to verify if the differences in
gene expression are also evident at the protein level, and
determine protein modifications that regress with differ-
ences in running capacity.
2 Materials and methods
2.1 Animal model
The inception of HCR-LCR strains from a founder popula-
tion of genetically heterogeneous N:NIH rats has been
described in detail [1]. In the current work, hearts from adult
male HCR and LCR rats (n 5 6 in each group) from
generation 22 were used. Animals were housed (two per
cage) in accordance with the University of Michigan
Committee guidelines on the use and care of animals.
Environmental conditions were 20721C, 40–50% relative
humidity with a 12 h light (0600–1800) and dark cycle. Food
and water were available ad libitum. Home cage activity was
measured gravimetrically during a 72 h period, as described
previously [8]. Non-fasting blood samples were collected
prior to the animals being killed. Serum glucose levels were
measured using an Accu-Chek glucose meter (Roche Diag-
nostics, Basel, Switzerland), serum insulin concentrations
were determined by ELISA using a commercially available
rodent assay (Linco Research, St. Charles, MO, USA).
2.2 Muscle processing
Animals were killed by cervical dislocation and their hearts
isolated and washed with saline before being blotted dry and
weighed. Cardiac septa were pulverised in liquid nitrogen
then homogenised on ice in lysis buffer: 7 M urea, 2 M
thiourea, 4% w/v CHAPS, 30 mM Tris, pH 8.5, at 41C,
containing Complete
TM
protease inhibitor (Roche Diag-
nostics). After centrifugation at 12 000 g, 41C for 45 min
supernatants were decanted, precipitated in acetone and
resuspended in DIGE lysis buffer. Insoluble proteins were
incubated in 1% v/v SDS and at 901C for 30 min then
washed twice in 0.1% w/v Rapigest SF (Waters; Milford,
MA, USA) in 50 mM ammonium bicarbonate using 5 kDa
Mr cut-off spin columns. Protein suspensions were
concentrated to 50 mL, then incubated at 801C for 15 min.
DTT was added (final concentration 1 mM) and incubated at
601C for 15 min followed by incubation in the presence of
5 mM iodoacetamide at 41C, protected from light. Sequen-
cing grade trypsin (Promega; Madison, WI, USA) was added
at a protein ratio of 1:50 and digestion allowed to proceed
at 371C overnight. Digestion was terminated by the addition
of 2mL concentrated HCl and peptide solutions centrifuged
at 13 000 g for 5 min to clear supernatants in preparation
for iTRAQ labelling and LC-MALDI-MS.
The protein/peptide concentrations were measured using
the Bradford assay (Sigma, Poole, Dorset, UK). Samples
prepared for DIGE were adjusted to 5mg/mL in lysis buffer.
2.3 DIGE of soluble cardiac proteins
Fifty microgram aliquots of each sample and the pooled
internal standard were labelled with 400 pmol CyDye DIGE
Fluor minimal dyes (GE Healthcare, Chalfont St. Giles,
UK), consistent with previous work [9]. Cy3 and Cy5 label-
ling was alternated between LCR and HCR samples in a
‘balanced’ design. Labelled LCR and HCR aliquots and
pooled Cy2-labelled standard were combined with rehydra-
tion buffer: 7 M urea, 2 M thiourea, 2% w/v CHAPS, 20 mM
DTT and 0.5% v/v ampholytes. IPG strips (24 cm, pH 3–11,
non-linear; Immoboline Drystrip, GE Healthcare) were
rehydrated overnight in 450 mL rehydration buffer that
contained the combined Cyanine-labelled samples. Isoelec-
tric focusing (maximum 50mA per strip) was performed on
an IPGPhor II (GE Healthcare) at 201C using the protocol
(total 44 000 Vh): 3 h at 300 V, 3 h at 600 V, 3 h at 1000 V,
gradient to 8000 V in 3 h then 4 h at 8000 V. IPG strips were
equilibrated in 50 mM Tris-HCl, pH 8.8, containing 6 M
urea, 30% v/v glycerol, 2% w/v SDS and bromophenol blue.
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DTT (10 mg/mL) was present in the first equilibration and
iodoacetamide (25 mg/mL) in the second. Proteins were
electrophoresed (Ettan Dalt six; GE healthcare) through
denaturing 12.5% polyacrylamide gels at 201C; at 5 W per
gel for 30 min, then 17 W per gel until the tracking dye
reached the bottom edge.
2.4 SameSpots protein expression profiling
Gels were digitised (16-bit greyscale, 100mm pixel size)
immediately after electrophoresis using a fluorescence
scanner (Typhoon 9400, GE Healthcare) at wavelengths
appropriate for Cy2, Cy3 and Cy5 dyes. Gel images (Cy2,
Cy3 and Cy5, total 5 18) were aligned using SameSpots
(Nonlinear Dynamics, Newcastle, UK). Prominent spots
(mean7SD per gel image: 548736) were used as vectors to
warp each image to a common reference gel. A mask was
used to remove gel artefacts (109 spots deleted) and features
with an average normalised volume o10 000 (147 spots) or
spot area o150 (33 spots) were disregarded. In total, 957
spots were included in the subsequent statistical analysis. As
a measure of technical variation, when ranked by coefficient
of variation, 70% of spots in Cy2 images (pooled standard)
had a coefficient of variation o14%.
Log-transformed spot volumes, expressed relative to the
pooled standard, were used to investigate differences in
expression between LCR and HCR groups by one-way
analysis of variance. To control false discovery rate (FDR),
the p-value distribution was used to calculate q-values and a
criterion FDR of 10% was set. This statistical approach,
which considers the biological variation across each spot, is
more sophisticated than arbitrary implementation of a
threshold based on fold-change. Associations between
serum insulin levels and differentially expressed spots (i.e.
po0.05, FDR o10%) were investigated by Pearson corre-
lation of HCR and LCR data using Prism 4.0 (GraphPad
Software, La Jolla, CA, USA).
2.5 Identification of gel spots using MALDI-MS/MS
and ESI-MS/MS
Spots were robotically excised from colloidal Coomassie-
stained (Bio-Safe; Bio-Rad, Hercules, CA, USA) preparative
gels loaded with 1.5 mg protein (pooled standard) and
proteins identified by MALDI-MS/MS analysis of in-gel
tryptic digests, as described previously [10]. Peak lists were
searched against the Swiss-Prot database (57.1) restricted to
‘Rattus’ (7347 sequences) using a locally implemented
MASCOT (www.matrixscience.com) server (version 2.2.03).
The enzyme specificity was trypsin allowing one missed
cleavage, carbamidomethyl modification of cysteine (fixed),
oxidation of methionine (variable) and an m/z error of
70.5 Da. Identification was accepted based on a significant
MOWSE score; the threshold (po0.05) was 51 using the
described database constraints. Up to three confirmatory MS/
MS spectra were automatically acquired from digests with
MOWSE scores o120. Selection of MS/MS fragment ion
spectra (average m/z) was restricted to 42 ions over six
segments encompassing 5–95% of the precursor ion m/z.
MS/MS ion lists were searched against the Swiss-Prot data-
base (tolerance 70.5 Da parent, 70.8 Da fragments) using
the constraints described for peptide mass fingerprinting.
Selected spots were analysed using nano LC-ESI-MS/MS.
Tandem electrospray mass spectra were recorded using a
quadrupole-high capacity ion-trap (HCT Ultra ETD II; Bruker
Daltonics, Bremen, Germany) coupled to a nano-flow HPLC
system (Ultimate 3000; Dionex, Sunnyvale, CA, USA). Five
microlitres of sample (in-gel digest) was injected and peptides
eluted using an ACN/0.1% formic acid gradient of 2–40% B
in 30 min at a flow rate of 300 nL/min (column Acclaim
PepMap 100, C18, 3mm, 100 Å, 75mm 15 cm, Dionex). An
online nanospray source (Bruker Daltonics) was used
equipped with a fused silica emitter (PicoTip FS360-20-10-D,
New Objective). The capillary voltage was–1300 V and a
survey scan from m/z 300 to 1500 was used to select peptides
with charge states of 12 or 13 using Enhanced Scan mode
(8100 (m/z)/s). Data-dependent MS/MS analysis in
alternating CID/electron transfer dissociation (ETD) mode
was performed selecting the two most abundant
precursor ions with active exclusion enabled. Data were
searched against the Swiss-Prot database (tolerance 71.3 Da
parent, 70.5 Da fragments) using the constraints
described for peptide mass fingerprinting with phosphoryla-
tion of serine, threonine or tyrosine residues as possible
modifications.
2.6 Analysis of insoluble cardiac proteins using
iTRAQ and LC-MALDI-MS/MS
Ten microgram aliquots of LCR and HCR samples and
pooled internal standard were labelled with iTRAQ reagents
according to the manufacturer’s instructions (Applied
Biosystems; Foster City, CA, USA). HCR and LCR samples
were labelled with iTRAQ 114, 115 or 116 in a ‘balanced’
design and combined with the pooled standard labelled with
iTRAQ 117 to produce 4-plex experiments. Samples, labelled
with iTRAQ reagents, were analysed in triplicate, as
described previously [11]. LC-MALDI automation software
selected 500 precursors in order of descending intensity
from chromatographic peaks of at least 20 s width. MS/MS
spectra were analysed for protein identification and parsed
with spectra of iTRAQ reporter ions (m/z 114, 115, 116 and
117) collected using the instrument’s low-mass zoom
feature. Data were searched against the Swiss-Prot database
using the constraints described for peptide mass finger-
printing with the addition of quantitation (iTRAQ 4-plex) as
a possible modification. Proteins with two or more iTRAQ
peptides with ions scores greater than the identity threshold
were selected for quantitation. Data expressed relative to the
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pooled internal standard were averaged from triplicate
analyses to create protein lists for each animal. Statistically
significant differences were determined using log-trans-
formed expression data.
2.7 Muscle enzyme activity
b-(3)-Hydroxyacyl-CoA dehydrogenase activity was measured
in muscle homogenates prepared in 100 mM K2HPO4 and
2 mM EDTA, pH 7.3 [12]. Homogenates were diluted in
100 mM K2HPO4, pH 7.3 containing 6.4 mM b-nicotinamide
adenine dinucleotide (NADH) and mixed with 5.4 mM
S-acetoacetyl-CoA to a final concentration of 97 mM K2HPO4,
0.1 mM b-NADH, 0.09 mM S-acetoacetyl-CoA. The rate of
disappearance of NADH was determined by measuring the
change in absorbance at 340 nm for 5 min at 371C.
2.8 Western blot analysis
Muscle powders were homogenised on ice in 1% w/v SDS
containing CompleteTM protease inhibitor (Roche Diag-
nostics) and centrifuged at 12 000 g, 41C for 20 min.
Supernatants were adjusted to 5 mg/mL protein in 2
Laemmli buffer and incubated at 901C for 5 min. Seventy-
five microgram aliquots of HCR and LCR proteins were
separated by SDS-PAGE and electro-transferred to PVDF
membranes. For immunoblotting of 2-DE gels, 500 mg
protein prepared for preparative gels was loaded on 13 cm,
pH 3–10, IPG strips (GE Healthcare) and transferred to
PVDF membranes as described previously [13]. Membranes
were blocked with 5% non-fat dried milk in 0.05% v/v
Tween-20 in PBS then incubated overnight at 41C with
primary antibodies specific for either 4-hydroxynonenal
(4-HNE; 1:1000 ab46544; Abcam, UK), a B-crystallin
(1:10000 ab13497; ABcam) or a B-crystallin phosphorylated
at serine 59 (1:2000 ab5577; Abcam) in 1% non-fat dried
milk Tween-20 in PBS. Secondary antibodies were from
Abcam (ab6741 (1:5000) and ab6721 (1:3000)) and immuno-
reactive proteins were detected by ECL (ECL Prime, GE
Healthcare) and quantified by densitometry. Equivalent
transfer of proteins was assessed by post-staining PVDF
membranes with Ponceau S or Direct Blue 71.
2.9 On-membrane MALDI-MS/MS
Protein spots visualised by anti-4-HNE immunoblotting
after 2-DE were identified by on-membrane MALDI-MS/
MS. Membranes were striped by incubation (45 min at
501C) in 100 mM DTT, 2% w/v SDS 52.5 mM Tris, pH 6.7,
and affixed to MALDI target plates using conductive tape.
Sequencing grade modified trypsin (0.2 mg/mL in 25 mM
Ammonium bicarbonate; Promega) was dispensed at the
positions (x, y coordinates) of immunoreactive proteins and
prominent ‘landmark’ spots using a piezoelectric printing
device (ChIP, Chemical Inkjet printer, Shimadzu Biotech).
One nano-litre spots were printed (ten intervals of 100 pL) at
a spacing of 500 mm within the border of each protein
position and on-membrane digestion was allowed to proceed
overnight at 371C in a humidified chamber. Spot positions
were over-printed (2 nL spots dispensed in intervals of
100 pL) with matrix solution (5 mg/mL CHCA in 50:50 ACN
and 0.1% TFA) and a calibration mix (Proteomass; Sigma)
consisting of bradykinin (m/z 756.39), angiotensin II (m/z
1046.54), P14R (m/z 1533.85) and adrenocorticotropic
hormone (ACTH) fragment (m/z 2465.19) was pipetted
(0.5 mL) in the target-plate calibration wells and overlaid with
0.5 mL matrix solution. Membranes were dried at 371C for
1 h prior to MALDI-MS/MS analysis directed at each protein
coordinate. Data were searched against the Swiss-Prot
database using the constraints described for peptide mass
fingerprinting.
3 Results
3.1 Exercise capacity of HCRs and LCRs
Rats in the founder population ran 355711 m during a
standardised run to exhaustion on a motorised treadmill [1].
Using an identical procedure, HCR rats from generation 22
ran 6.2-fold further than LCRs when they were 3 months old
(1864740 versus 29976 m) and four-fold further (754724
versus 185710 m) prior to isolation of the hearts at 12
months of age. At each assessment HCRs performed
significantly more running work compared with LCRs.
Habitual cage activity during either light or dark periods was
not significantly different in HCRs and LCRs (Supporting
Information Table 1). Serum glucose (mg/dL) was not
different (196.3723 in HCRs versus 195.3722 in LCRs)
whereas serum insulin (ng/mL) was significantly
(po0.0001) greater in LCRs (4.8470.5) compared with
HCRs (1.3270.2). Gross and lean body weights of HCRs
were less than LCRs and the absolute wet weight of the
hearts was significantly greater in HCRs, equating to a 1.5-
fold greater heart: lean body mass ratio (Supporting Infor-
mation Table 1).
3.2 DIGE analysis of soluble cardiac proteins
Differential analysis was performed on 957 spots and the
expression of 67 gel spots was significantly (FDR o10%)
different between HCRs and LCRs. MS unambiguously
identified proteins in 369 gel spots (Supporting Information
Table 2), including 56 of the differentially expressed spots. A
2-D gel map of the proteins identified by MS is available in
the World 2D-PAGE repository (http://world-2dpage.expa-
sy.org/repository/), accession number 0022 and a repre-
sentative pseudo-colour image of the DIGE separation is
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available online (Supporting Information Fig. 1). This
proteome mining work revealed majority of proteins were
resolved as multi-spot series. Thus, the 369 identified gel-
spots comprise 170 gene products and, in total, DIGE and
MS analysis identified 39 gene products that were differ-
entially expressed between HCRs and LCRs (Table 1).
Further to differences between HCR and LCR group means,
significant correlation was found between individual serum
insulin concentrations in LCRs and the abundance of
coronin-6 (spot 1; R2 5 0.7410, p 5 0.0277) and propionyl-
CoA carboxylase a-chain (spot 23; R2 0.662, p 5 0.0489)
whereas low serum insulin levels in HCRs correlated with
the abundance of hydroxyacyl-CoA dehydrogenase (spot 80;
R2 5 0.907, p 5 0.0034), succinyl-CoA: 3-ketoacid coenzyme
A (R2 5 0.8587, p 5 0.0079), ventricular myosin regulatory
light chain (spot 83; R2 5 0.8295, p 5 0.0116) and protein
disulfide-isomerase A3 (Spot 45; R2 5 0.6869, p 5 0.0415).
3.3 iTRAQ analysis of insoluble cardiac proteins
Twenty-eight proteins met the inclusion criteria for iTRAQ
analysis (Supporting Information Table 3) and the expres-
sion of six proteins differed significantly (po0.05) between
HCRs and LCRs (Table 2). iTRAQ detected 11 gene
products (3-keto acyl-co-enzyme A (acyl-CoA) thiolase, ADP/
ATP translocase 1, citrate synthase, cytochrome c oxidase
subunit 4 isoform 1, cytochrome c oxidase subunit 5A,
cytoplasmic dynein, fatty acid-binding protein, haemoglobin
subunit a-1/2, haemoglobin subunit b-1, myosin-6 and
myosin-7) not observed using DIGE. Four of these proteins
(3-keto acyl-CoA thiolase, ADP/ATP translocase 1, cyto-
chrome c oxidase subunit 4 isoform 1 and cytochrome c
oxidase subunit 5A) were differentially expressed between
HCRs and LCRs. Three proteins (ATP synthase subunit a,
isocitrate dehydrogenase and myosin regulatory light
chain 2) identified as differentially expressed using DIGE
were also detected in the iTRAQ analysis. In each case no
significant difference was detected using iTRAQ, which is
consistent with our previous experience [11].
3.4 Biochemical and immunoblot analyses
The proteomic analyses point to differences in b-oxidation of
fatty acids and exposure to oxidative stress. b-(3)-Hydroxyacyl-
CoA dehydrogenase activity is commonly used as a measure
of b-oxidation capacity and was 1.3-fold greater in HCR
(75.473.3 versus 56.773.3mmol/g/min, p 5 0.002), whereas
proteins associated with exposure to H2O2 and lipid perox-
idation, such as 4-HNE, were detected in LCR hearts.
Western blotting detected a prominent 4-HNE-reactive band
at 45 kDa that was significantly (p 5 0.015) more abundant
in LCRs (Fig. 1). Immunoblot analysis of 2-DE separated
proteins revealed two 4-HNE immunoreactive spots in LCR
hearts (Fig. 1D), which were each identified as long-chain
specific acyl-CoA dehydrogenase (ACADL) and correspond to
spots 651 and 627 of the DIGE map. a B-crystallin is an
abundant small heat shock protein in cardiac muscle and was
resolved as three discrete isoelectric species (spots 20, 640 and
717) using DIGE. Spot 20 was 1.67-fold greater in LCRs and
nano flow liquid chromatography (nLC)-ESI-MS/MS revealed
this spot contained peptides phosphorylated at S59 that were
not present in spot 640 or 717 (Fig. 2). Western blotting
further confirmed the ratio of phosphorylated (S59) to total a
B-crystallin was significantly greater in LCRs (Fig. 2F).
4 Discussion
Proteomic analysis revealed selection on running capacity is
associated with changes in cardiac energy metabolism and
discovered the first evidence that the cardiac proteome of
LCRs is exposed to greater oxidative stress. These findings
closely support the conclusions of our [7] microarray inves-
tigation but, in the majority, proteomic analysis discovered
new information rather than simply providing protein-level
confirmation of earlier reported [7] differences in gene
expression. The limited direct correspondence between
proteome and transcriptome data is, in part, due to the
larger number of genes assayed by microarray compared to
DIGE. In addition, it is important to recognise the majority
of proteins were resolved as multiple spots using 2-DE;
therefore, differences in spot expression may indicate
differences in post-translational modification and provide
information not evident at the transcriptome level.
The current work revealed conspicuous differences in
b-oxidation enzymes suggesting an enhanced capacity for
fatty acid oxidation in HCRs. Specifically, DIGE detected
pronounced modulation of each enzyme of the matrix
component of the b-oxidation pathway (Table 1) responsible
for oxidation of short-chain fatty acyl-CoA [14]. Accordingly,
b-hydroxyacyl-CoA dehydrogenase activity was significantly
greater in HCRs and the abundance of this key enzyme
closely correlated with low serum insulin concentrations in
these animals. Modulation of short-chain specific acyl-CoA
dehydrogenase (ACADS) was a prominent feature in the
current analysis. ACADS was observed as multiple spots
(4, 10, 11 and 14) and the abundance of the most basic
species (spot 11) was two-fold greater in LCRs, whereas,
spots 4, 10 and 14 were two-fold greater in HCRs. These
isoelectric species may represent different post-translational
states, for example phosphorylated species of ACADS have
been reported [15]. In the current work nLC-ESI-MS/MS
analysis identified 84% of the ACADS sequence (57 unique
peptides, MOWSE score 5 2806), but did not include phos-
phorylated residues. Nonetheless, the ACADS spot pattern
in HCRs closely resembles that of endurance-trained
rats [10], and putative post-translational modulation of
ACADS is a consistent feature associated with changes in
cardiac performance. For example, genetic deletion of
phospholamban, which produces a hyper-dynamic cardiac
Proteomics 2011, 11, 3369–3379 3373
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Table 1. DIGE expression data
Description Protein ID Ref] HCR norm. vol. LCR norm. vol. Fold diff.
Energy metabolism
Fatty acid metabolism
Short-chain specific acyl-CoA dehydrogenase P15651 11 0.74170.018 1.51770.167 12.05
Short-chain specific acyl-CoA dehydrogenase P15651 4 1.43270.038 0.59470.232 2.41
Short-chain specific acyl-CoA dehydrogenase P15651 10 1.40970.055 0.66570.196 2.12
Short-chain specific acyl-CoA dehydrogenase P15651 14 1.19870.056 0.66870.118 1.79
Enoyl-CoA hydratase, mitochondrial P14604 105 1.13870.016 0.97170.01 1.17
Enoyl-CoA hydratase, mitochondrial P14604 127 1.02170.019 0.8970.021 1.15
Enoyl-CoA hydratase, mitochondrial P14604 174 0.96370.017 0.8870.013 1.09
Hydroxyacyl-CoA dehydrogenase Q9WVK7 80 1.37870.052 1.13070.048 1.22
Hydroxyacyl-CoA dehydrogenase Q9WVK7 143 1.17570.011 1.03970.036 1.13
Acyl-coenzyme A thioesterase 2 O55171 30 1.10470.056 0.770.077 1.58
Acyl-coenzyme A thioesterase 2 O55171 61 1.11370.033 0.87870.023 1.27
Amino acid degradation
Propionyl-CoA carboxylase a chain P14882 22 1.42270.052 0.86170.083 1.65
Propionyl-CoA carboxylase a chain P14882 23 0.87370.115 1.42170.043 11.63
d-1-Pyrroline-5-carboxylate dehydrogenase P0C2X9 29 0.81570.049 1.29370.051 11.59
Methylcrotonoyl-CoA carboxylase subunit a Q5I0C3 53 0.84170.029 1.09870.067 11.31
Ketone body metabolism
Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 B2GV06 17 0.94170.088 1.62870.215 11.73
Acetyl-CoA acetyltransferase P17764 41 1.3370.065 0.9270.066 1.45
Acetyl-CoA acetyltransferase P17764 152 0.96570.015 1.08270.024 11.21
Glycolytic metabolism
Dihydrolipoyllysine-residue acetyltransferase
component of pyruvate dehydrogenase complex
P08461 147 1.05370.018 0.93570.028 1.13
Glycogen phosphorylase, muscle form P09812 47 1.11770.085 0.80570.051 1.39
Tricarboxylic acid cycle
Fumarate hydratase, mitochondrial P14408 5 1.47870.067 0.62070.147 2.38
Fumarate hydratase, mitochondrial P14408 6 1.51670.062 0.64970.146 2.33
Isocitrate dehydrogenase (NADP) P56574 129 0.98770.033 1.13170.018 11.15
2-Oxoglutarate dehydrogenase E1 component Q5XI78 70 0.97770.043 1.21870.041 11.25
Electron transport chain
Succinate dehydrogenase [ubiquinone] iron-sulfur subunit P21913 182 1.09770.005 1.07370.006 1.02
Electron transfer flavoprotein subunit a P13803 121 0.97570.021 0.84370.032 1.16
Electron transfer flavoprotein-ubiquinone oxidoreductase Q6UPE1 91 0.99470.041 0.83570.028 1.19
Cytochrome b-c1 complex subunit 2 P32551 77 1.19770.039 0.97970.041 1.22
ATP synthase subunit a P15999 164 0.99470.009 1.09970.027 11.11
Voltage-dependent anion-selective channel protein 1 Q9Z2L0 137 0.99670.026 0.87670.023 1.14
Antioxidant/stress response
Catalase P04762 19 0.71370.049 1.21270.053 11.70
Catalase P04762 42 0.93270.072 1.32970.073 11.43
Aldehyde dehydrogenase 2 P11884 124 0.9270.028 1.05870.033 11.15
Glutathione S-transferase Mu 2 P08010 2 1.61870.189 0.54270.167 2.99
Protein disulfide-isomerase A3 P11598 13 1.47270.062 0.79970.15 1.84
Protein disulfide-isomerase A3 P11598 37 1.22270.054 0.80970.096 1.51
Protein disulfide-isomerase A3 P11598 45 1.26270.069 0.90970.055 1.39
Heat shock protein b-7 (Fragment) Q9QUK5 7 1.41970.259 0.6170.057 2.33
a-Crystallin B chain P23928 20 0.76870.094 1.28270.133 11.67
Myofibrillar and cytoskeletal
Myosin regulatory light chain 2, ventricular/cardiac muscle P08733 66 0.98870.031 1.24570.038 11.26
Myosin regulatory light chain 2, ventricular/cardiac muscle P08733 83 0.95070.041 1.1570.043 11.21
Desmin P48675 60 0.8870.03 1.11870.049 11.27
Desmin P48675 169 1.02270.02 1.12570.023 11.10
Vimentin P31000 15 1.37370.222 0.77170.044 1.78
EH domain-containing protein 1 Q641Z6 25 0.75570.044 1.21370.029 11.61
EH domain-containing protein 1 Q641Z6 50 0.86170.036 1.14770.025 11.33
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phenotype, is associated with a similar shift in ACADS spot
pattern [16], and elevated expression of low-pI ACADS spots
in hearts of swim-trained rats correlates with enhanced
ACADS activity [17].
Differential expression of b-oxidation enzymes coincided
with differences in electron transfer proteins and compo-
nents of the respiratory chain. This may indicate tighter
coupling specifically between b-oxidation of short-chain fatty
acyl-CoA and oxidative phosphorylation that is important for
enhanced aerobic capacity. Acyl-CoA dehydrogenases reduce
flavin adenine dinucleotide (FADH2) and transfer electrons
to electron transfer flavoprotein-ubiquinone oxidoreductase
via electron transfer flavoprotein-a, driving the reduction of
ubiquinone. Both electron transfer flavoprotein-a and elec-
tron transfer flavoprotein-ubiquinone oxidoreductase were
identified as multi-spot series and the expression of indivi-
dual spots within these series was significantly different in
HCR and LCR hearts. In addition, subunit 2 of cytochrome
b-c1, was 1.22-fold less in LCRs and iTRAQ detected 1.9-fold
lower abundance of subunit 1 of cytochrome b-c1 and
1.67-fold lesser abundance of cytochrome c oxidase subu-
nits 4 and 5A in LCRs. These findings are consistent with
enrichment of fatty acid oxidation genes reported in the
HCR transcriptome. Furthermore, DIGE provided protein-
level confirmation of the elevated mRNA expression of acyl-
CoA thioesterase 2 (mitochondrial thioesterase 1: MTE-1) in
HCRs [7]. MTE-1 hydrolyses fatty acyl-CoA to its free fatty
acid anion, which may be exported from the mitochondrion
[18]. MTE-1 is also modulated in endurance-trained hearts
[10] and this adaptation may serve to protect the inner
mitochondrial membrane by preventing accumulation of
acyl-carnitine, which is a strong surfactant and can damage
lipid membranes [19].
The observed differences in metabolic enzymes may be
related to impaired peroxisome proliferator activated recep-
tor (PPAR)-a signalling in LCRs. The PPAR gene ontology
pathway was overrepresented in microarray analysis [7] of
HCR-LCR hearts, and some genes of the modulated
proteins involved in b-oxidation (Table 1) have PPAR-
responsive elements [20]. Interestingly, metabolomic
profiling of PPARa/ mice [21] reveals a compensatory
increase in leucine metabolism. Degradation of branched-
Table 1. Continued
Description Protein ID Ref] HCR norm. vol. LCR norm. vol. Fold diff.
Coronin-6 Q920J3 1 0.44670.046 1.97270.485 14.42
Rab GDP dissociation inhibitor a P50398 56 1.14970.054 0.89870.047 1.28
PDZ and LIM domain protein 1 P52944 64 1.05470.036 0.83570.049 1.26
Miscellaneous
Annexin A3 P14669 150 1.05370.029 0.93770.022 1.12
Apolipoprotein E P02650 89 0.90370.041 1.07670.019 11.19
Prostaglandin reductase 2 Q5BK81 9 1.67370.221 0.73370.188 2.28
Proteasome activator complex subunit 1 Q63797 133 0.85970.01 0.9870.033 11.14
Pyridoxine-50-phosphate oxidase O88794 39 1.44370.043 0.9970.14 1.46
Protein description and Protein ID relate to the Swiss-Prot database (57.1) entry identified from MASCOT searches of MS and MS/MS
spectra. HCR and LCR expression ratios are average7SD relative to the pooled internal standard. Fold difference relative to HCR values
are reported for spots exhibiting significant (po0.05) differences in expression at an FDR of o10%.
Table 2. iTRAQ analysis of insoluble protein fraction
Description Swiss-
Prot ID
MOWSE HCR LCR Difference
(p-value)
3-Ketoacyl-CoA thiolase, mitochondrial P13437 7074 1.69070.665 0.90370.165 1.872 (0.01)
ADP/ATP translocase 1 Q05962 119712 1.80270.856 0.7270.253 2.503 (0.025)
Cytochrome b-c1 complex subunit 1, mitochondrial Q68FY0 79724 1.05370.088 0.55370.229 1.904 (0.003)
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial P10888 7074 1.25870.164 0.74870.374 1.682 (0.024)
Cytochrome c oxidase subunit 5A, mitochondrial P11240 6975 1.17070.198 0.70270.313 1.667 (0.023)
Tropomyosin a-1 chain P04692 159749 0.54070.277 1.06070.153 11.963 (0.01)
Protein description, database name and ID relate to the Swiss-Prot database (57.1) entry returned using the MASCOT search engine.
A MOWSE score greater than 51 denotes a confident (po0.05) protein identification. HCR and LCR expression ratios are the average7SD
of peptides quantified in each sample expressed relative to the pooled internal standard. Fold difference relative to HCR values is reported
and p-values were determined from log-transformed data using Student’s independent t-tests. The complete list of proteins identified by
iTRAQ and the average7SD number of MS/MS ions analysed and the average7SD peptides that met the inclusion criteria for iTRAQ
analysis (including amino acid sequences identified) are reported in Supporting Information Table 3.
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chain amino acids, in particular leucine, is ketogenic and
DIGE detected modulation of methylcortonyl-CoA carbox-
ylase subunit-a and propionyl-CoA carboxylase a-chain,
which contribute to branched-chain amino acid degradation
or b-oxidation of odd chain-length and methyl-branched
fatty acyl-CoA. Moreover, succinyl-CoA: 3-ketoacid-coen-
zyme A transferase 1 (spot 17), which catalyses the rate-
limiting step in ketolysis, was more abundant in LCR hearts
and low serum insulin concentrations in HCRs correlated
with low abundance of this enzyme. The second reaction in
ketolysis is catalysed by acetyl-CoA acetyltransferase and this
protein was detected in two spots, the abundance of spot 41
was 1.5-fold less, whereas, spot 152 was 1.2-fold greater in
LCRs suggesting a shift in post-translational state of this
enzyme. As yet, it is not possible to determine whether these
findings depict altered amino acid degradation only, or
concurrent differences in ketone body and amino acid
degradation in LCRs.
The lesser abundance of b-oxidation and electron trans-
port chain enzymes in LCRs indicates diminished mito-
chondrial capacity, which may be associated with greater
oxidative stress and H2O2 production that can cause irre-
versible damage to macromolecules. Indeed, catalase, which
scavenges H2O2, was significantly more abundant in LCRs
and two proteins, aldehyde dehydrogenase-2 and gluta-
thione S-transferase, that defend against lipid peroxidation
products such as 4-HNE were also differentially expressed.
Phosphorylation of aldehyde dehydrogenase-2 protects
against ischaemic damage to the heart [22] and this protein
was modulated in a manner suggesting post-translational
modification in LCRs, whereas, glutathione S-transferase
was less abundant in LCRs, which is consistent with find-
ings in hearts of spontaneously hypertensive rats [23].
Thyfault et al. [24] report elevated catalase activity and
higher levels of 4-HNE-modified proteins associated with
hepatic steatosis in LCRs. Using a similar approach, we
detected a greater abundance of 4-HNE-modified ACADL in
LCR heart (Fig. 1), which may be linked to the observed
modulation of enzymes specifically responsible for b-oxida-
tion of short-chain fatty acids. Recently, Tweedie et al. [25]
reported greater activity of catalase and superoxide dismu-
tase in skeletal muscle of HCR, which is in contrast to the
findings in heart and liver. In the current work, superoxide
dismutase and other key enzymes of the antioxidant defense
system, including glutathione peroxidase, were detected by
DIGE but were not different between HCRs and LCRs.
Selection on running capacity resulted in differential
expression of chaperone proteins, including protein disul-
fide isomerase A3, heat shock protein b-7 (cardiovascular
heat shock protein) and a B-crystallin. The expression of
cardiovascular heat shock protein was 2.33-fold less in LCRs
and protein disulfide isomerase A3, which was resolved as
three spots, was on average 1.6-fold less in LCRs. aB-
crystallin was also resolved as three spots (20, 640 and 717)
and the abundance of phosphorylated (S59) a B-crystallin
(spot 20) was 1.67-fold greater in LCRs (Fig. 2). Phosphor-
ylation of a B-crystallin at S59 is associated with protection
against a variety of different environmental stresses. For
example, exposure of cardiomyoblasts to H2O2 activates the
p38 mitogen-activated protein kinase (MAPK)/mitogen and
stress-activated protein kinase 1 pathway resulting in phos-
phorylation of a B-crystallin S59 [26]; similarly ischaemia/
reperfusion injury activates p38 MAPK and is associated
with S59 phosphorylation [27]. Therefore, the greater phos-
phorylation of a B-crystallin S59 observed here (Fig. 2) is
consistent with enrichment of the stress-activated p38
MAPK signalling in the LCR cardiac transcriptome [7].
Phosphorylated a B-crystallin is also associated with
cytoskeletal stress whereupon this chaperone translocates
and interacts with desmin [28]. Elevated expression of
desmin is a feature of human cardiomyopathy [29] and was
also observed in LCR hearts (Table 1). Moreover, cytoskeletal
Figure 1. 4-HNE modification of ACADL. Western blot analysis
(A) of 4-HNE-modified proteins detected a prominent band at
45–50 kDa that was more abundant in LCR hearts (B). Homo-
genates of LCR (C and D) and HCR (E and F) hearts were sepa-
rated by 2-DE and transferred to PVDF membranes. Proteins
were visualised by Ponceau S staining (C and E) or immunoblot
analysis of 4-HNE-modified residues (D and F). 4-HNE immuno-
reactive spots and prominent spots stained by Direct Blue 71
were identified by MS analysis of on-membrane tryptic digests.
Two 4-HNE immunoreactive spots, corresponding to ]651 and
]627 of the DIGE map, were more intensely labelled in LCR
hearts (D) and were identified as ACADL.
3376 J. G. Burniston et al. Proteomics 2011, 11, 3369–3379
& 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
stress induced by pressure overload increases microtubule
density [30], while overexpression of a B-crystallin helps to
maintain cardiomyocyte microtubule integrity [31]. Coronin-
6 exhibited the greatest difference (4.4-fold greater in LCRs)
in abundance between HCRs and LCRs and correlated
significantly with high serum insulin levels in LCRs. Coro-
nin proteins cross-link actin filaments [32] and may also
interact with microtubules linking this novel discovery with
over-representation of microtubule-based processes in
LCRs [7]. The role of coronin-6 in cardiac muscle is yet to be
described but changes in the expression of coronin 1 are
associated with the transition to maladaptive cardiac hyper-
trophy induced by transgenic overexpression of myotrophin
[33]. Changes in microtubule proteins are consistent with
elevated oxidative stress [34] and proteasomal dysfunction
[35], which may contribute to the development of cardio-
myopathy [36]. Accordingly, LCRs exhibited greater expres-
sion of proteasome activator complex subunit 1. Cardiac
expression of proteasome activator complex subunit 1 is
elevated in diabetic cardiomyopathy induced by streptozoto-
cin, and Powell et al [37] report the 11S-activated proteasome,
rather than the 26S-proteasome, is associated with the
degradation oxidatively modified proteins.
Post-genomic investigations afford comprehensive
unbiased analysis that can advance knowledge and generate
novel hypotheses. However, despite using sophisticated
statistical analyses, the large number of dependent variables
often raises concerns regarding false discoveries. Therefore,
validation is important. Duplication of proteomic experi-
ments or the inclusion of technical replicates does not
provide validation of the biological significance of the
original discoveries. Instead, comparison of data across
associated biological models is a more relevant approach.
Features of the HCR cardiac proteome, including ACADS
and MTE-1, were identical to endurance-trained rat hearts
[38] and, therefore, may represent key molecular events
associated with enhanced aerobic capacity. Similarly, LCRs
exhibited molecular features consistent with animal models
of cardiomyopathy. For example, Turko and Murad [39]
report modulation of b-oxidation enzymes and differential
Figure 2. Phosphorylation of a B-crystallin at S59. Spots 20, 640 and 717 were unambiguously identified as a B-crystallin and the
expression of spot 20 was 1.67-fold greater in LCR (A and B). nLC-MS/MS detected a doubly charged precursor (m/z 779.86) of peptide
APSWIDTGLSEMR (residues 57–69) in spot 20 that was not present in spot 640 or spot 717. Site-specific mapping of serine phosphor-
ylation was performed using (C) CID and (D) ETD techniques. (E) Interpretation of fragment ion spectra confirmed oxidation of methionine
68 and phosphorylation of serine 59; bold underlined type denotes modified residues. MOWSE peptide scores from CID and ETD
fragmentation were 55 and 80, respectively. (F) Western blot analysis confirmed the ratio of a B-crystallin phosphorylated serine 59
relative to total a B-crystallin was significantly greater (1.49-fold; p 5 0.02) in LCR hearts.
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expression of voltage-dependent anion channel 1 and
catalase in hearts of streptozotocin-induced diabetic rats.
Faber et al. [40] found differences in desmin and a B-crys-
tallin expression after pressure-induced cardiomyopathy.
Bugger et al. [41] report robust down-regulation of enzymes
involved in fatty acid oxidation after 20 wk of aortic
constriction, and Meng et al. [42] reveal changes in fatty
acid metabolism contribute to cardiac hypertrophy and
precede the development of hypertension in spontaneously
hypertensive rats.
The correspondence between LCRs and models of cardi-
omyopathy is testament to the importance of low aerobic
capacity in the development of disease. Our discoveries
support the thesis that, in normal populations, a decline in
physical activity resulting in low aerobic capacity is the
antecedent of hypertension and overt cardiac dysfunction. In
humans, heart failure is a progressive and complex condition
involving both inherited and environmental factors that co-
occurs with other complicated risks including hypertension,
obesity and insulin resistance. Thus, the use of acute models
or inbred strains such as spontaneously hypertensive rat is
limited. The LCR-HCR model retains genetic complexity.
LCRs manifest many of the features associated with meta-
bolic syndrome, and here we show the cardiac proteome of
LCRs is exposed to greater oxidative stress and metabolic
perturbations that may underlie their diminished cardiac
performance. In contrast, despite low levels of habitual
physical activity, HCRs appear to be uniquely protected from
cardiometabolic disease and demonstrate an enhanced capa-
city to utilise fatty acids for cardiac work similar to endurance-
trained animals. As such, further interrogation of this model
may provide additional clues or even reveal the molecular
mechanisms that underlie the complexity of low heart func-
tion as a precursor to heart failure.
The 2-D DIGE map associated with this work is available at
the World -2DPAGE repository, URL: http://world-2dpage.
expasy.org/repository/database=0022.
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